Lulinext Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits potent fungicidal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lulinext Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis. The formulation allows for effective skin penetration, ensuring targeted antifungal action with minimal systemic absorption. It is applied once daily to the affected area and surrounding skin, typically for a duration of 2 to 4 weeks depending on the severity and site of infection. Clinical studies have demonstrated Luliconazole’s superior efficacy and tolerability compared to other topical antifungals. Common adverse effects are generally mild and may include localized burning, itching, or erythema at the application site. Lulinext Cream should be used with caution in patients with known hypersensitivity to imidazole antifungals. It is not intended for use in mucosal or systemic fungal infections. Proper hygiene and adherence to the prescribed regimen enhance therapeutic outcomes and reduce the risk of recurrence.